📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Omeicos

1.1 - Company Overview

Omeicos Logo

Omeicos

Headquarter: Germany
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of first-in-class small-molecule therapeutics based on omega-3 fatty acid metabolites for the treatment and prevention of atrial fibrillation and broader indications. Offers OMT-28, a synthetic analog of 17,18-EEQ for cardiovascular inflammation and mitochondrial dysfunction; conducts the PMD-OPTION study in Primary Mitochondrial Disease; and develops a pipeline of proprietary omega-3 analogs for cardiovascular, inflammatory, and mitochondrial diseases.

Products and services

  • OMT-28: A novel, first-in-class synthetic small‑molecule analog of omega‑3 metabolite 17,18‑EEQ, engineered to reduce cardiovascular inflammation and mitochondrial dysfunction, with potential ophthalmology applications via a new Mode of Action
  • Pipeline Development: A broad proprietary library of omega‑3 fatty‑acid analog compounds architected for various therapeutic applications across cardiovascular, inflammatory, and mitochondrial diseases
  • PMD-OPTION Study: A clinical study assessing OMT‑28’s efficacy and safety in Primary Mitochondrial Disease patients, focusing on lowering mitochondrial stress biomarkers and inflammation.

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Omeicos

R3 Vascular Logo

R3 Vascular

HQ: United States Website
  • Description: Provider of medical devices for peripheral artery disease, including the MAGNITUDE Bioresorbable Sirolimus-Eluting Scaffold (BRS), which maintains vessel support, delivers sirolimus to prevent restenosis, and gradually resorbs into tissue.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full R3 Vascular company profile →
Unetixs Vascular Logo

Unetixs Vascular

HQ: United Kingdom Website
  • Description: Provider of somatic vascular devices, manufacturing high-tech products in the country.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Unetixs Vascular company profile →
Inovise Logo

Inovise

HQ: United States Website
  • Description: Provider of diagnostic medical technology focused on diagnostic cardiology, patient monitoring, and biomedical engineering.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Inovise company profile →
Pathway Medical Logo

Pathway Medical

HQ: United States Website
  • Description: Provider of medical devices for the treatment of arterial and vascular diseases, designing, developing, manufacturing, and marketing these devices.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pathway Medical company profile →
Wright Therapy Logo

Wright Therapy

HQ: United States Website
  • Description: Provider of home compression therapy solutions and devices for treating lymphedema and chronic venous insufficiency, with a history of innovation including the first sequential gradient pneumatic compression device.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Wright Therapy company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Omeicos

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Omeicos

2.2 - Growth funds investing in similar companies to Omeicos

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Omeicos

4.2 - Public trading comparable groups for Omeicos

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Omeicos

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Omeicos

What does Omeicos do?

Omeicos is a provider of first-in-class small-molecule therapeutics based on omega-3 fatty acid metabolites for the treatment and prevention of atrial fibrillation and broader indications. Offers OMT-28, a synthetic analog of 17,18-EEQ for cardiovascular inflammation and mitochondrial dysfunction; conducts the PMD-OPTION study in Primary Mitochondrial Disease; and develops a pipeline of proprietary omega-3 analogs for cardiovascular, inflammatory, and mitochondrial diseases.

Who are Omeicos's competitors?

Omeicos's competitors and similar companies include R3 Vascular, Unetixs Vascular, Inovise, Pathway Medical, and Wright Therapy.

Where is Omeicos headquartered?

Omeicos is headquartered in Germany.

How many employees does Omeicos have?

Omeicos has 1,000 employees 🔒.

When was Omeicos founded?

Omeicos was founded in 2010 🔒.

What sector and industry vertical is Omeicos in?

Omeicos is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Omeicos

Who are the top strategic acquirers in Omeicos's sector and industry

Top strategic M&A buyers and acquirers in Omeicos's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Omeicos?

Top strategic M&A buyers groups and sectors for Omeicos include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Omeicos's sector and industry vertical

Which are the top PE firms investing in Omeicos's sector and industry vertical?

Top PE firms investing in Omeicos's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Omeicos's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Omeicos's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Omeicos's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Omeicos include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Omeicos's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Omeicos?

The key public trading comparables and valuation benchmarks for Omeicos include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Omeicos for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Omeicos with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Omeicos's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Omeicos with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Omeicos's' sector and industry vertical?

Access recent funding rounds and capital raises in Omeicos's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Omeicos